Kodiak Sciences Inc (KOD): Price and Financial Metrics


Kodiak Sciences Inc (KOD): $8.08

0.30 (+3.86%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add KOD to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

KOD Stock Price Chart Interactive Chart >

Price chart for KOD

KOD Price/Volume Stats

Current price $8.08 52-week high $13.40
Prev. close $7.78 52-week low $4.90
Day low $7.81 Volume 207,700
Day high $8.48 Avg. volume 189,285
50-day MA $7.53 Dividend yield N/A
200-day MA $8.02 Market Cap 422.66M

Kodiak Sciences Inc (KOD) Company Bio


Kodiak Sciences is a clinical stage biopharma specializing in therapeutics to treat chronic retinal diseases. The company was founded in 2005 and is based in New York City, New York.


KOD Latest News Stream


Event/Time News Detail
Loading, please wait...

KOD Latest Social Stream


Loading social stream, please wait...

View Full KOD Social Stream

Latest KOD News From Around the Web

Below are the latest news stories about KODIAK SCIENCES INC that investors may wish to consider to help them evaluate KOD as an investment opportunity.

Kodiak Sciences to Present at the 41st Annual J.P. Morgan Healthcare Conference

Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, announced today that management will present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 11, 2023, at 9:00 a.m. Pacific Time (12:00 p.m. Eastern Time).

Yahoo | January 4, 2023

Thinking Of Investing In Kodiak Sciences Inc. (NASDAQ: KOD) Stock? Read This First

Kodiak Sciences Inc. (NASDAQ:KOD) shares, rose in value on Friday, 12/30/22, with the stock price up by 4.22% to the previous day’s close as strong demand from buyers drove the stock to $7.16. Actively observing the price movement in the last trading, the stock closed the session at $6.87, falling within a range of $6.68 … Thinking Of Investing In Kodiak Sciences Inc. (NASDAQ: KOD) Stock? Read This First Read More »

Stocks Register | December 31, 2022

Kodiak Sciences Inc. (KOD) Up 1% Since Last Earnings Report: Can It Continue?

Kodiak Sciences Inc. (KOD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | December 9, 2022

Does Kodiak Sciences Inc. (KOD) Have the Potential to Rally 87% as Wall Street Analysts Expect?

The consensus price target hints at an 87.4% upside potential for Kodiak Sciences Inc. (KOD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Yahoo | November 30, 2022

Kodiak Sciences to Present at the Evercore ISI 5th Annual HealthCONx Conference

Kodiak Sciences Inc. (NASDAQ: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, announced today that management will present virtually at the Evercore ISI 5th Annual HealthCONx Conference on Tuesday, November 29, 2022, at 9:10am Pacific Time (12:10pm Eastern Time).

Yahoo | November 16, 2022

Read More 'KOD' Stories Here

KOD Price Returns

1-mo N/A
3-mo 15.26%
6-mo -17.04%
1-year -35.12%
3-year -33.85%
5-year N/A
YTD 12.85%
2022 -57.77%
2021 -42.29%
2020 104.18%
2019 913.38%
2018 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6696 seconds.